.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Dow
Citi
Argus Health
Moodys
McKinsey
Chubb
Express Scripts
US Department of Justice
Boehringer Ingelheim

Generated: November 22, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title:Method for reducing transplant rejection in the eye and intraocular implants for use therefor
Abstract: Methods for reducing or preventing transplant rejection in the eye of an individual are described, comprising: a) performing an ocular transplant procedure; and b) implanting in the eye a bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer.
Inventor(s): Wong; Vernon G. (Menlo Park, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Filing Date:Apr 26, 2013
Application Number:13/871,214
Claims:1. A method for reducing transplant rejection in an eye of an individual, the method comprising: a) performing an ocular transplant procedure on an eye of an individual; and b) implanting in the vitreous cavity of the eye a bioerodible implant consisting of an immunosuppressive agent and a polylactic acid polyglycolic acid (PLGA) copolymer, thereby reducing transplant rejection in the eye, wherein the implant is produced by an extrusion method and wherein the total weight of the implant is about 1000 pg.

2. The method of claim 1, wherein the immunosuppressive agent is dexamethasone.

3. The method of claim 2, wherein the PLGA copolymer is a 50/50 PLGA copolymer.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Johnson and Johnson
Moodys
Cantor Fitzgerald
Queensland Health
Julphar
Covington
McKesson
Fish and Richardson
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot